Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
1992
174
LTM Revenue $60.3M
LTM EBITDA $12.2M
$223M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Electromed has a last 12-month revenue of $60.3M and a last 12-month EBITDA of $12.2M.
In the most recent fiscal year, Electromed achieved revenue of $54.7M and an EBITDA of $7.4M.
Electromed expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Electromed valuation multiples based on analyst estimatesFY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $41.7M | $48.1M | $54.7M | $60.3M | XXX |
Gross Profit | $31.4M | $36.5M | $41.7M | XXX | XXX |
Gross Margin | 75% | 76% | 76% | XXX | XXX |
EBITDA | $3.6M | $4.6M | $7.4M | $12.2M | XXX |
EBITDA Margin | 9% | 10% | 14% | 20% | XXX |
Net Profit | $2.3M | $3.2M | $5.2M | XXX | XXX |
Net Margin | 6% | 7% | 9% | XXX | XXX |
Net Debt | n/a | n/a | n/a | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 21, 2025, Electromed's stock price is $28.
Electromed has current market cap of $239M, and EV of $223M.
See Electromed trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$223M | $239M | XXX | XXX | XXX | XXX | $0.73 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 21, 2025, Electromed has market cap of $239M and EV of $223M.
Electromed's trades at 3.7x LTM EV/Revenue multiple, and 18.4x LTM EBITDA.
Analysts estimate Electromed's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Electromed and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $223M | XXX | XXX | XXX |
EV/Revenue | 3.8x | XXX | XXX | XXX |
EV/EBITDA | 21.0x | XXX | XXX | XXX |
P/E | 38.4x | XXX | XXX | XXX |
P/E/Growth | 1.5x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpElectromed's NTM/LTM revenue growth is 13%
Electromed's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Electromed's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Electromed's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Electromed and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 14% | XXX | XXX | XXX | XXX |
EBITDA Margin | 18% | XXX | XXX | XXX | XXX |
EBITDA Growth | 61% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 31% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
Opex to Revenue | 64% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
Senseonics Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Electromed acquired XXX companies to date.
Last acquisition by Electromed was XXXXXXXX, XXXXX XXXXX XXXXXX . Electromed acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Electromed founded? | Electromed was founded in 1992. |
Where is Electromed headquartered? | Electromed is headquartered in United States of America. |
How many employees does Electromed have? | As of today, Electromed has 174 employees. |
Who is the CEO of Electromed? | Electromed's CEO is Mr. James L. Cunniff. |
Is Electromed publicy listed? | Yes, Electromed is a public company listed on ASE. |
What is the stock symbol of Electromed? | Electromed trades under ELMD ticker. |
When did Electromed go public? | Electromed went public in 2010. |
Who are competitors of Electromed? | Similar companies to Electromed include e.g. Philips, Perspective Therapeutics, InfuSystem, Myomo. |
What is the current market cap of Electromed? | Electromed's current market cap is $239M |
What is the current revenue of Electromed? | Electromed's last 12-month revenue is $60.3M. |
What is the current EBITDA of Electromed? | Electromed's last 12-month EBITDA is $12.2M. |
What is the current EV/Revenue multiple of Electromed? | Current revenue multiple of Electromed is 3.7x. |
What is the current EV/EBITDA multiple of Electromed? | Current EBITDA multiple of Electromed is 18.4x. |
What is the current revenue growth of Electromed? | Electromed revenue growth between 2023 and 2024 was 14%. |
Is Electromed profitable? | Yes, Electromed is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.